Company: BIAF
Filing Date: 2025-05-23
Form Type: PRER14A
Source: 0001641172-25-012315
Chunk: 45

Company: bioAffinity Technologies, Inc.
Filing Date: 2025-05-23
Form: PRER14A
Chunk 45
---
 accordance with the terms thereof. Notwithstanding the foregoing, in the event of a Fundamental Transaction, the holders of the New
Warrants have the right to require the Company or a successor entity to redeem the New Warrants for cash in the amount of the Black Scholes
Value (as defined in the New Warrant) of the unexercised portion of the New Warrants concurrently with or within 30 days following the
consummation of a Fundamental Transaction. However, in the event of a Fundamental Transaction which is not in our control, including
a Fundamental Transaction not approved by the Company’s Board, the holders of the New Warrants will only be entitled to receive
from the Company or its successor entity, as of the date of consummation of such Fundamental Transaction, the same type or form of consideration
(and in the same proportion), at the Black-Scholes Value of the unexercised portion of the New Warrant that is being offered and paid
to the holders of Common Stock in connection with the Fundamental Transaction, whether that consideration is in the form of cash, stock,
or any combination of cash and stock, or whether the holders of our Common Stock are given the choice to receive alternative forms
of consideration in connection with the Fundamental Transaction.

| 24 |

The Advisor
Warrants have substantially the same terms as the New Warrants, except that they are immediately exercisable and expire on the five-year
anniversary of the date of issuance. In addition, the Advisor Warrants may be exercised in a “cashless” manner if at any
time after the six-month anniversary of the date of issuance, there is no effective registration statement under the Securities
Act for the resale of the shares of Common Stock issuable upon exercise of the Advisor Warrants.

We agreed in the Inducement Agreement
to file a registration statement to register the resale of the New Warrant Shares (the “Resale Registration Statement”)
within 45 calendar days of February 26, 2025, (the date of the Inducement Agreement) and to use commercially reasonable efforts
to have the Resale Registration Statement declared effective by the SEC and to keep such registration statement effective at all times
until the Holders no longer own any New Warrants or New Warrant Shares.

Reasons for the Warrant Exercise Proposal

Our Common Stock is listed on Nasdaq
and trades under the ticker symbol “BIAF.” Nasdaq Listing Rule 5635(d) requires stockholder approval of transactions other